Sam D. Stephen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sam D. Stephen has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Claudia Guida
Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Oxford, UK
2 shared publications- Reshma Ramracheya
Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, UK
2 shared publications Bruno Sgromo
Oxford Bariatric Service, Oxford University Hospitals NHS Foundation Trust, Oxford, UK
1 shared publicationChun-Mei Zhao
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway
1 shared publicationDuan Chen
Department of Clinical and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway
1 shared publication- Fiona Mary Gribble
University of Cambridge
1 shared publication
Latest Publications
- Open Access
- 1 February 2019
- Published by Elsevier in EBioMedicine
- Vol. 40, 67-76
PYY plays a key role in the resolution of diabetes following bariatric surgery in humans
- 1 February 2019
- Published by Elsevier in EBioMedicine
- Vol. 40, 67-76
Open AccessPYY plays a key role in the resolution of diabetes following bariatric surgery in humans
- 1 August 2017
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 28 (8) , 626-636
The Role of PYY in Pancreatic Islet Physiology and Surgical Control of Diabetes
- 1 August 2017
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 28 (8) , 626-636
The Role of PYY in Pancreatic Islet Physiology and Surgical Control of Diabetes
- Open Access
- 1 December 2010
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 24 (12) , 2315-2330
Interferon Tau Regulates PGF2α Release from the Ovine Endometrial Epithelial Cells via Activation of Novel JAK/EGFR/ERK/EGR-1 Pathways
In ruminants, pulsatile release of prostaglandin F2α (PGF2α) from the endometrium is transported to the ovary and induces luteolysis thereby allowing new estrous cycle. Interferon tau (IFNT), a type 1 IFN secreted by the trophoblast cells of the developing conceptus, acts on endometrial luminal epithelial (LE) cells and inhibits pulsatile release of PGF2α and establishes pregnancy. One of the unknown mechanisms is that endometrial pulsatile release of PGF2α is inhibited whereas basal release of PGF2α is increased in pregnant compared with nonpregnant sheep. We have recently found that pulsatile release of PGF2α from the endometrium is regulated by prostaglandin transporter (PGT)-mediated mechanisms. We hypothesize that modulation in the endometrial pulsatile vs. basal release of PGF2α likely requires PGT-mediated selective transport, and IFNT interacts with PGT protein and modulates pulsatile vs. basal release of PGF2α. The new findings of the present study are: 1) IFNT activates novel JAK-SRC kinase-EGFR-RAS-RAF-ERK1/2-early growth response (EGR)-1 signaling module in LE cells; 2) IFNT increases interactions between PGT and ERK1/2 or EGR-1 proteins and alters phosphorylation of PGT protein; 3) IFNT precludes action of protein kinase C and Ca2+ on PGT function; and 4) IFNT inhibits 80% PGT-mediated but not 20% simple diffusion-mediated release of PGF2α from the endometrial LE cells through this novel signaling module. The results of the present study provide important new insights on IFNT signaling and molecular control of PGT-mediated release of PGF2α and unravel the underlying mechanisms responsible for the increased basal release of PGF2α at the time of establishment of pregnancy in ruminants.
- 1 December 2010
- Published by The Endocrine Society in Molecular Endocrinology
- Vol. 24 (12) , 2315-2330
Open AccessInterferon Tau Regulates PGF2α Release from the Ovine Endometrial Epithelial Cells via Activation of Novel JAK/EGFR/ERK/EGR-1 Pathways
In ruminants, pulsatile release of prostaglandin F2α (PGF2α) from the endometrium is transported to the ovary and induces luteolysis thereby allowing new estrous cycle. Interferon tau (IFNT), a type 1 IFN secreted by the trophoblast cells of the developing conceptus, acts on endometrial luminal epithelial (LE) cells and inhibits pulsatile release of PGF2α and establishes pregnancy. One of the unknown mechanisms is that endometrial pulsatile release of PGF2α is inhibited whereas basal release of PGF2α is increased in pregnant compared with nonpregnant sheep. We have recently found that pulsatile release of PGF2α from the endometrium is regulated by prostaglandin transporter (PGT)-mediated mechanisms. We hypothesize that modulation in the endometrial pulsatile vs. basal release of PGF2α likely requires PGT-mediated selective transport, and IFNT interacts with PGT protein and modulates pulsatile vs. basal release of PGF2α. The new findings of the present study are: 1) IFNT activates novel JAK-SRC kinase-EGFR-RAS-RAF-ERK1/2-early growth response (EGR)-1 signaling module in LE cells; 2) IFNT increases interactions between PGT and ERK1/2 or EGR-1 proteins and alters phosphorylation of PGT protein; 3) IFNT precludes action of protein kinase C and Ca2+ on PGT function; and 4) IFNT inhibits 80% PGT-mediated but not 20% simple diffusion-mediated release of PGF2α from the endometrial LE cells through this novel signaling module. The results of the present study provide important new insights on IFNT signaling and molecular control of PGT-mediated release of PGF2α and unravel the underlying mechanisms responsible for the increased basal release of PGF2α at the time of establishment of pregnancy in ruminants.